| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vincerx Pharma, Inc. (VINC) has 0 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. VINC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2022 | Bushnell Laura I. | Director | Buy | 15,000 | $1.91 | $28,624.50 | +357.0% | |
| Dec 23, 2021 | Hwang Sooin | Chief Business Officer | Buy | 3,000 | $10.00 | $30,000.00 | +0.8% | |
| Dec 22, 2021 | Thomas Tom C | See Remarks | Buy | 1,000 | $10.23 | $10,230.00 | +50.0% | |
| Dec 22, 2021 | Seelenberger Alexander A. | Chief Financial Officer | Buy | 2,417 | $10.34 | $24,987.91 | +24.0% | |
| Dec 22, 2021 | Hamdy Ahmed Md | Chief Executive Officer | Buy | 6,450 | $10.02 | $64,649.64 | +82.4% | |
| Dec 22, 2021 | Bushnell Laura I. | Director | Buy | 2,402 | $10.48 | $25,172.96 | +133.4% | |
| Aug 4, 2021 | Izumi Raquel E. | See Remarks | Buy | 1,000 | $11.96 | $11,960.00 | New | |
| Jun 30, 2021 | Bushnell Laura I. | Director | Buy | 1,800 | $12.94 | $23,297.40 | New | |
| Jun 30, 2021 | Hwang Sooin | Chief Business Officer | Buy | 500 | $12.66 | $6,330.00 | +0.1% | |
| Jun 30, 2021 | Lowe Christopher P.77 | Director | Buy | 10,000 | $12.62 | $126,152.00 | +156.3% |